Bioplus participated in the 2019 Intercharm UKRAIN held in Kiev, Ukraine, for three days from September 18, 199.
Ukraine, a newly emerging and emerging leading market, has seen more than 100 percent growth in the plastic surgery and beauty market every year, and is even more anticipated because Korean companies have not yet entered the market.
This exhibition is the largest beauty fair in Ukraine and has the scale and recognit...
BioPlus Co., Ltd. received permission to manufacture veterinary medical devices from the Animal Drug Management Division on July 18, 2019. In addition, the approval of the 'Dressing, deep- cavity wound (adhesion inhibitor)' for animals was completed.
In Korea, the number of pets is increasing due to the increase of single-person households and the aging population, and the market size is growing every year.
BioPlus participated in C-Medical Fair, one of China's largest medical device exhibition in Shanghai, from July 11-13, 2019.
‘The C-Medical Fair covers comprehensive products, including medical electronic products, medical imaging equipment, ward nursing and auxiliary equipment,medical supplies and hygienic materials, testing equipment and diagnostic reagents, optical products, first aid products, rehabilitation nursing product...
BioPlus Co., Ltd., a manufacturer specializing in fillers, obtained the Medical Device Single Screening Program (MDSAP) certification on 23 June.
The Medical Device Single Audit Program (MDSAP) is a system that certifies medical devices that meet the criteria requirements through a single review at the International Medical Device Regulatory Forum (IMDRF) for medical device safety and quality control.
-Acceleration of market expansion through overseas market development
BioPlus Co., Ltd. launched new product InterBlock on February 26.
Inter Block, an anti-adhesive barrier agent for spine (domestic market) , is a product produced using pure HA (hyaluronic acid) without using chemical thickeners and can provide a safe and complete anti-adhesion effect...
HyalDew obtained its INVIMA (The Colombia National Food and Drug Surveillance Institute) certificate on May 30 of 2017, opening a new door for entering the South American market.
The medical device market in Colombia stands at 1.2 billion USD in 2014, ranked 4th among the Latin American countries and expecting to boost to 2.2 billion USD in 2018. (business monitor International)
BioPlus Co., Ltd. successfully finalized the AMWC 2017 held in Monaco from April 6 to April 8.
The booth located at Diaghilev hall stand G21.
The annual Aesthetic & Anti-Aging Medicine World Congress (AMWC) 2017 opened up its 15th exhibition in Monaco from April 6 to April 8 under the sponsorship of H.S.H. Prince Albert II. The AMWC held at Grimaldi Forum in Monte Carlo, Monaco, hosts a 35,000 meter square of exhibition and...
BioPlus Co., Ltd. participated at the the Dubai Derma 2017 held in Dubai from March 27 to March 29. The booth, located at stand number 5B04, was at the IBITA pavillion with other renowned Korean companies in the medical device sector.
The Dubai World Dermatology & Laser Conference & Exhibition is a unique event held annually at the Dubai International Convention and Exhibition Centre, UAE that is dedicated to practitioners...
BioPlus Co., Ltd. attending the KIMES 2017 held in Seoul from March 16 to March 19.
The booth was located at stand number L127, at the entrance of Hall B.
The Korea International Medical & Hospital Equipment Show (KIMES), held its 34th Annual exhibition. It is Korea's largest medical and hospital equipment exhibition held at COEX in seoul with a space of 38,500 meters square. It hosts over 1,200 exhibitors from mo...